Skip to main content
Premium Trial:

Request an Annual Quote

Mark Gardner

OmniSeq has appointed Mark Gardner as its CEO and as a member of its board of directors. Gardner is currently vice president and general manager for Thermo Fisher Scientific's next generation clinical sequencing business. He will transition to his new role at OmniSeq in April. Prior to his work at Thermo Fisher, Gardner held senior management positions at McKinsey, GE Medical Systems, Invitrogen, and Life Technologies.